MA29662B1 - Compositions pour l'apport de medicaments hautement solubles dans l'eau - Google Patents
Compositions pour l'apport de medicaments hautement solubles dans l'eauInfo
- Publication number
- MA29662B1 MA29662B1 MA29665A MA29665A MA29662B1 MA 29662 B1 MA29662 B1 MA 29662B1 MA 29665 A MA29665 A MA 29665A MA 29665 A MA29665 A MA 29665A MA 29662 B1 MA29662 B1 MA 29662B1
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- delivery
- highly water
- soluble drugs
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne des compositions pour l'apport de médicaments hautement solubles dans l'eau (p. ex. alcaloïdes de la pervenche) et des procédés d'utilisation de ces compositions.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/889,226 US7871632B2 (en) | 2004-07-12 | 2004-07-12 | Compositions for delivering highly water soluble drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29662B1 true MA29662B1 (fr) | 2008-08-01 |
Family
ID=35541622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29665A MA29662B1 (fr) | 2004-07-12 | 2007-02-06 | Compositions pour l'apport de medicaments hautement solubles dans l'eau |
Country Status (19)
Country | Link |
---|---|
US (4) | US7871632B2 (fr) |
EP (1) | EP1773294A4 (fr) |
JP (1) | JP4643641B2 (fr) |
KR (1) | KR20070032816A (fr) |
CN (1) | CN1859898B (fr) |
AU (1) | AU2005271873A1 (fr) |
BR (1) | BRPI0513178A (fr) |
CA (1) | CA2578574C (fr) |
EA (1) | EA012522B1 (fr) |
EC (1) | ECSP077238A (fr) |
HK (1) | HK1100062A1 (fr) |
IL (1) | IL180350A0 (fr) |
MA (1) | MA29662B1 (fr) |
MX (1) | MX2007000416A (fr) |
NO (1) | NO20070785L (fr) |
RS (1) | RS20070029A (fr) |
TW (1) | TW200607525A (fr) |
WO (1) | WO2006017246A2 (fr) |
ZA (1) | ZA200701167B (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2575216A1 (fr) * | 2004-07-28 | 2006-02-09 | Sd Pharmaceuticals, Inc. | Composition injectable stable de succinate alpha tocopherile, d'analogue et de sels de ce compose |
US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
CN101011355B (zh) * | 2006-02-01 | 2013-01-02 | 陈献 | 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途 |
TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
EP2023895A2 (fr) * | 2006-05-12 | 2009-02-18 | Adventrx Pharmaceuticals, Inc. | Compositions pharmaceutiques pour médicaments irritants pour les veines |
WO2009078756A1 (fr) | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Système d'administration de médicament pour administrer une substance pharmaceutiquement acceptable amphiphile, cationique et hydrosoluble |
WO2009078754A1 (fr) | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Système d'administration de médicament permettant d'administrer des substances pharmaceutiquement actives faiblement hydrosolubles |
US8063020B2 (en) * | 2007-12-22 | 2011-11-22 | Simpkins Cuthbert O | Resuscitation fluid |
US8618056B2 (en) * | 2007-12-22 | 2013-12-31 | Cuthbert O. Simpkins | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
US8906855B2 (en) * | 2007-12-22 | 2014-12-09 | Vivacelle Bio, Inc. | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
RU2010139478A (ru) * | 2008-02-25 | 2012-05-20 | Новавакс, Инк. (Us) | Соединенные с сахарным стеклом вирусоподобные частицы (vlp) |
US20090286832A1 (en) * | 2008-05-15 | 2009-11-19 | Kiichiro Nabeta | Narcotic emulsion formulations for treatment of surgical pain |
MX2011007885A (es) | 2009-02-26 | 2011-12-08 | Techno Guard Co Ltd | Formulaciones de emulsion de narcoticos para tratamiento de dolor por cancer. |
CN101879138A (zh) | 2009-05-06 | 2010-11-10 | 上海恒瑞医药有限公司 | 长春花生物碱纳米乳剂注射液及其制备方法 |
RU2642234C2 (ru) * | 2009-08-14 | 2018-01-24 | ОПКО Хельс, Инк. | Композиции антагонистов нейрокинина-1 для внутривенного введения |
SI2629779T1 (sl) * | 2010-10-22 | 2017-11-30 | Dr. Reddy's Laboratories Sa. | Uporaba za skladiščenje stabilnega viskoznega fosfolipidnega depoja za oskrbo ran |
WO2012135856A2 (fr) * | 2011-04-01 | 2012-10-04 | Spectrum Pharmaceuticals, Inc. | Vinorelbine à très faible dose pour le traitement du cancer |
CN102743337B (zh) * | 2011-04-20 | 2014-04-16 | 国家纳米科学中心 | 一种纳米粒子药物组合物及其制备方法 |
CA2838739A1 (fr) * | 2011-06-09 | 2012-12-13 | Hailiang Chen | Compositions de gels |
EP3915545A1 (fr) | 2011-10-25 | 2021-12-01 | The University of British Columbia | Nanoparticules lipides de taille limite, et procédés correspondants |
US9668974B2 (en) | 2012-05-10 | 2017-06-06 | Painreform Ltd. | Depot formulations of a local anesthetic and methods for preparation thereof |
US20140275261A1 (en) | 2013-03-15 | 2014-09-18 | Dr. Reddy's Laboratories, Inc. | Diclofenac parenteral compositions |
CA2906732C (fr) | 2013-03-15 | 2023-08-08 | The University Of British Columbia | Nanoparticules lipidiques pour la transfection et procedes associes |
US20160290093A1 (en) * | 2015-04-02 | 2016-10-06 | Baker Hughes Incorporated | Disintegrating Compression Set Plug with Short Mandrel |
KR20180039726A (ko) | 2015-09-04 | 2018-04-18 | 더 캘리포니아 인스티튜트 포 바이오메디칼 리써치 | 인슐린 면역글로불린 융합 단백질 |
WO2022107843A1 (fr) * | 2020-11-19 | 2022-05-27 | 日本化薬株式会社 | Composition contenant un médicament soluble dans l'eau capable d'induire un trouble vasculaire, solution destinée à être utilisée dans la préparation d'une solution à administrer contenant un médicament soluble dans l'eau capable d'induire un trouble vasculaire, kit, agent de prévention de troubles vasculaires et solution contenant un tensioactif non ionique |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US224042A (en) * | 1880-02-03 | Music-rest for piano-fortes | ||
US670001A (en) * | 1900-02-15 | 1901-03-19 | Stephen B Morss | Combined curb and gutter. |
US4816247A (en) | 1985-09-11 | 1989-03-28 | American Cyanamid Company | Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs |
IL88076A (en) * | 1987-10-28 | 1993-01-14 | Nippon Shinyaku Co Ltd | Fat emulsions as drug carriers |
EP0473707A4 (en) | 1989-05-26 | 1992-12-09 | Abbott Laboratories | Injectable clarithromycin composition |
US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
WO1997009986A1 (fr) | 1995-09-13 | 1997-03-20 | Nippon Shinyaku Co., Ltd. | Preparation lyophilisee contenant de la pge1 et son procede de production |
JP2001503735A (ja) * | 1996-07-03 | 2001-03-21 | ユニバーシティ オブ ピッツバーグ | 親水性活性試薬のためのエマルジョン処方物 |
ES2241133T3 (es) * | 1997-04-28 | 2005-10-16 | Encysive Pharmaceuticals Inc. | Sulfamidas para el tratamiento de los trastornos inducidos por la endotelina. |
US6723338B1 (en) | 1999-04-01 | 2004-04-20 | Inex Pharmaceuticals Corporation | Compositions and methods for treating lymphoma |
US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
GB9925127D0 (en) | 1999-10-22 | 1999-12-22 | Pharmacia & Upjohn Spa | Oral formulations for anti-tumor compounds |
US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
JP2003277281A (ja) * | 2002-03-20 | 2003-10-02 | Kumamoto Technology & Industry Foundation | 静脈炎の予防及び治療のための医薬 |
US6890558B2 (en) | 2002-05-31 | 2005-05-10 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
JP4426749B2 (ja) * | 2002-07-11 | 2010-03-03 | 株式会社産学連携機構九州 | O/w型エマルション製剤 |
US20050049209A1 (en) * | 2003-08-06 | 2005-03-03 | Chen Andrew Xian | Pharmaceutical compositions for delivering macrolides |
CA2575216A1 (fr) * | 2004-07-28 | 2006-02-09 | Sd Pharmaceuticals, Inc. | Composition injectable stable de succinate alpha tocopherile, d'analogue et de sels de ce compose |
CN1634058A (zh) * | 2004-10-20 | 2005-07-06 | 李晓祥 | 长春瑞滨乳剂及其制备方法 |
-
2004
- 2004-07-12 US US10/889,226 patent/US7871632B2/en not_active Expired - Fee Related
-
2005
- 2005-07-12 WO PCT/US2005/024594 patent/WO2006017246A2/fr active Application Filing
- 2005-07-12 EA EA200700312A patent/EA012522B1/ru not_active IP Right Cessation
- 2005-07-12 MX MX2007000416A patent/MX2007000416A/es unknown
- 2005-07-12 BR BRPI0513178-2A patent/BRPI0513178A/pt not_active IP Right Cessation
- 2005-07-12 CN CN2005800005998A patent/CN1859898B/zh not_active Expired - Fee Related
- 2005-07-12 EP EP05772989A patent/EP1773294A4/fr not_active Withdrawn
- 2005-07-12 TW TW094123650A patent/TW200607525A/zh unknown
- 2005-07-12 RS RSP-2007/0029A patent/RS20070029A/sr unknown
- 2005-07-12 CA CA2578574A patent/CA2578574C/fr not_active Expired - Fee Related
- 2005-07-12 AU AU2005271873A patent/AU2005271873A1/en not_active Abandoned
- 2005-07-12 KR KR1020077003386A patent/KR20070032816A/ko not_active Application Discontinuation
- 2005-07-12 JP JP2007521547A patent/JP4643641B2/ja not_active Expired - Fee Related
-
2006
- 2006-12-26 IL IL180350A patent/IL180350A0/en unknown
-
2007
- 2007-02-06 MA MA29665A patent/MA29662B1/fr unknown
- 2007-02-08 ZA ZA200701167A patent/ZA200701167B/xx unknown
- 2007-02-09 NO NO20070785A patent/NO20070785L/no not_active Application Discontinuation
- 2007-02-12 EC EC2007007238A patent/ECSP077238A/es unknown
- 2007-05-08 HK HK07104920.0A patent/HK1100062A1/xx not_active IP Right Cessation
-
2010
- 2010-12-10 US US12/965,676 patent/US8026250B2/en not_active Expired - Fee Related
-
2011
- 2011-08-17 US US13/212,140 patent/US8222268B2/en not_active Expired - Fee Related
-
2012
- 2012-06-21 US US13/530,039 patent/US20130029918A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20070785L (no) | 2007-04-02 |
CN1859898B (zh) | 2011-06-08 |
AU2005271873A1 (en) | 2006-02-16 |
US7871632B2 (en) | 2011-01-18 |
CA2578574C (fr) | 2013-09-10 |
TW200607525A (en) | 2006-03-01 |
ECSP077238A (es) | 2007-04-26 |
WO2006017246A2 (fr) | 2006-02-16 |
ZA200701167B (en) | 2010-08-25 |
JP4643641B2 (ja) | 2011-03-02 |
HK1100062A1 (en) | 2007-09-07 |
US20120046310A1 (en) | 2012-02-23 |
US8026250B2 (en) | 2011-09-27 |
WO2006017246A3 (fr) | 2006-03-30 |
US8222268B2 (en) | 2012-07-17 |
JP2008505972A (ja) | 2008-02-28 |
RS20070029A (en) | 2008-11-28 |
BRPI0513178A (pt) | 2008-04-29 |
CA2578574A1 (fr) | 2006-02-16 |
EA200700312A1 (ru) | 2007-08-31 |
US20110082168A1 (en) | 2011-04-07 |
EP1773294A4 (fr) | 2012-11-21 |
US20130029918A1 (en) | 2013-01-31 |
IL180350A0 (en) | 2007-06-03 |
US20060008480A1 (en) | 2006-01-12 |
EA012522B1 (ru) | 2009-10-30 |
MX2007000416A (es) | 2007-03-28 |
KR20070032816A (ko) | 2007-03-22 |
EP1773294A2 (fr) | 2007-04-18 |
CN1859898A (zh) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29662B1 (fr) | Compositions pour l'apport de medicaments hautement solubles dans l'eau | |
WO2007051062A3 (fr) | Dihydropyridines substituees et leurs methodes d'utilisation | |
WO2007149406A8 (fr) | Polypeptides facteurs ix de la coagulation modifiés et leur utilisation thérapeutique | |
WO2002070438A3 (fr) | Compositions permettant l'administration de biophosphonates | |
WO2006060547A3 (fr) | Systemes et methodes d'administration intra-orale de medicaments | |
EP2279732A3 (fr) | Composés et compositions pour la distribution d'agents actifs | |
IL176519A0 (en) | Directly compressible pharmaceutical composition for the oral administration of cci-779 | |
UA96449C2 (en) | Stable laquinimod preparations | |
TW200635897A (en) | Piperidine derivatives and their use as anti-inflammatory agents | |
WO2005115398A3 (fr) | Inhibiteurs d'integrase de vih | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
FR2851470B1 (fr) | Composition pharmaceutique pour administration transdermique ou transmuqueuse | |
WO2007025005A3 (fr) | Formulations de nalbuphine a liberation prolongee | |
WO2006002077A3 (fr) | Formulations pharmaceutiques stables de composes de benzimidazole | |
IS8051A (is) | Kladríbínefnablöndur til inngjafar um munn | |
WO2009071689A3 (fr) | Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
DK1551803T3 (da) | Azabicycloderivater som muskarine receptorantagonister | |
NO20064783L (no) | Opplosningstabeletter med licarbazepin | |
WO2006064228A3 (fr) | Composes | |
WO2004093805A3 (fr) | Modulateurs des recepteurs aux glucocorticoides spirocycliques selectifs | |
WO2003041656A3 (fr) | Systeme de liberation prolongee de medicaments solubles | |
MX2007004461A (es) | Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico. | |
TW200503783A (en) | Oral pharmaceutical preparation for proton pump antagonists | |
MX2008002272A (es) | Compuestos de ciclopropilo y composiciones para suministrar agentes activos. |